Financial Instruments (Tables)
|
9 Months Ended |
Sep. 30, 2019 |
| Financial Instruments |
|
| Financial assets and financial liabilities measured at fair value on a recurring basis |
| | | | | | | | | | | | | | (Dollars in millions) | | | | | | | | | | | | | | At September 30, 2019 | | Level 1 | | Level 2 | | Level 3 | | Total | | Assets: | | | | | | | | | | | | | | Cash equivalents (1) | | | | | | | | | | | | | | Time deposits and certificates of deposit | | $ | — | | $ | 6,251 | | $ | — | | $ | 6,251 | (6) | Money market funds | | | 597 | | | — | | | — | | | 597 | | Total | | $ | 597 | | $ | 6,251 | | $ | — | | $ | 6,848 | | Equity investments (2) | | | 0 | | | — | | | — | | | 0 | | Debt securities – current (3) | | | — | | | 733 | | | — | | | 733 | (6) | Debt securities – noncurrent (2) | | | — | | | 111 | | | — | | | 111 | (6) | Derivative assets (4) | | | 4 | | | 533 | | | — | | | 536 | | Total assets | | $ | 601 | | $ | 7,628 | | $ | — | | $ | 8,229 | | Liabilities: | | | | | | | | | | | | | | Derivative liabilities (5) | | $ | — | | $ | 1,074 | | $ | — | | $ | 1,074 | |
| (1) | Included within cash and cash equivalents in the Consolidated Statement of Financial Position. |
| (2) | Included within investments and sundry assets in the Consolidated Statement of Financial Position. |
| (3) | Included within marketable securities in the Consolidated Statement of Financial Position. |
| (4) | The gross balances of derivative assets contained within prepaid expenses and other current assets, and investments and sundry assets in the Consolidated Statement of Financial Position at September 30, 2019 were $395 million and $141 million, respectively. |
| (5) | The gross balances of derivative liabilities contained within other accrued expenses and liabilities, and other liabilities in the Consolidated Statement of Financial Position at September 30, 2019 were $203 million and $870 million, respectively. |
| (6) | Available-for-sale debt securities with carrying values that approximate fair value. |
| | | | | | | | | | | | | | (Dollars in millions) | | | | | | | | | | | | | | At December 31, 2018 | | Level 1 | | Level 2 | | Level 3 | | Total | | Assets: | | | | | | | | | | | | | | Cash equivalents (1) | | | | | | | | | | | | | | Time deposits and certificates of deposit | | $ | — | | $ | 7,679 | | $ | — | | $ | 7,679 | (6) | Money market funds | | | 25 | | | — | | | — | | | 25 | | Total | | $ | 25 | | $ | 7,679 | | $ | — | | $ | 7,704 | | Equity investments (2) | | | 0 | | | — | | | — | | | 0 | | Debt securities – current (3) | | | — | | | 618 | | | — | | | 618 | (6) | Derivative assets (4) | | | 1 | | | 731 | | | — | | | 731 | | Total assets | | $ | 26 | | $ | 9,028 | | $ | — | | $ | 9,053 | | Liabilities: | | | | | | | | | | | | | | Derivative liabilities (5) | | $ | 40 | | $ | 343 | | $ | — | | $ | 383 | |
| (1) | Included within cash and cash equivalents in the Consolidated Statement of Financial Position. |
| (2) | Included within investments and sundry assets in the Consolidated Statement of Financial Position. |
| (3) | Included within marketable securities in the Consolidated Statement of Financial Position. |
| (4) | The gross balances of derivative assets contained within prepaid expenses and other current assets, and investments and sundry assets in the Consolidated Statement of Financial Position at December 31, 2018 were $385 million and $347 million, respectively. |
| (5) | The gross balances of derivative liabilities contained within other accrued expenses and liabilities, and other liabilities in the Consolidated Statement of Financial Position at December 31, 2018 were $177 million and $206 million, respectively. |
| (6) | Available-for-sale debt securities with carrying values that approximate fair value. |
|
| Fair Values of Derivative Instruments in the Consolidated Statement of Financial Position |
| | | | | | | | | | | | | | | | | | | Fair Value of Derivative Assets | | Fair Value of Derivative Liabilities | | | Balance Sheet | | | | | | | | Balance Sheet | | | | | | | (Dollars in millions) | | Classification | | 9/30/2019 | | 12/31/2018 | | Classification | | 9/30/2019 | | 12/31/2018 | Designated as hedging instruments: | | | | | | | | | | | | | | | | | Interest rate contracts | | Prepaid expenses and other current assets | | $ | 9 | | $ | 9 | | Other accrued expenses and liabilities | | $ | — | | $ | 4 | | | Investments and sundry assets | | | 106 | | | 212 | | Other liabilities | | | 2 | | | 76 | Foreign exchange contracts | | Prepaid expenses and other current assets | | | 368 | | | 348 | | Other accrued expenses and liabilities | | | 165 | | | 110 | | | Investments and sundry assets | | | 35 | | | 135 | | Other liabilities | | | 869 | | | 129 | | | Fair value of derivative assets | | $ | 518 | | $ | 704 | | Fair value of derivative liabilities | | $ | 1,035 | | $ | 320 | Not designated as hedging instruments: | | | | | | | | | | | | | | | | | Foreign exchange contracts | | Prepaid expenses and other current assets | | $ | 12 | | $ | 26 | | Other accrued expenses and liabilities | | $ | 36 | | $ | 13 | Equity contracts | | Prepaid expenses and other current assets | | | 6 | | | 2 | | Other accrued expenses and liabilities | | | 2 | | | 51 | | | Fair value of derivative assets | | $ | 18 | | $ | 28 | | Fair value of derivative liabilities | | $ | 38 | | $ | 63 | Total derivatives | | | | $ | 536 | | $ | 731 | | | | $ | 1,074 | | $ | 383 | Total debt designated as hedging instruments (1): | | | | | | | | | | | | | | | | | Short-term debt | | | | | N/A | | | N/A | | | | $ | — | | $ | — | Long-term debt | | | | | N/A | | | N/A | | | | | 6,061 | | | 6,261 | | | | | | N/A | | | N/A | | | | $ | 6,061 | | $ | 6,261 | Total | | | | $ | 536 | | $ | 731 | | | | $ | 7,134 | | $ | 6,644 |
| (1) | Debt designated as hedging instruments are reported at carrying value. |
N/A - not applicable
|
| Amounts related to cumulative basis adjustments for fair value hedges |
| | | | | | | | | | September 30, | | December 31, | | (Dollars in millions) | | 2019 | | 2018 | | Short-term debt: | | | | | | | | Carrying amount of the hedged item | | $ | (326) | | $ | (1,878) | | Cumulative hedging adjustments included in the carrying amount - assets/(liabilities) | | | (1) | (1) | | (4) | (1) | Long-term debt: | | | | | | | | Carrying amount of the hedged item | | $ | (4,834) | | $ | (6,004) | | Cumulative hedging adjustments included in the carrying amount - assets/(liabilities) | | | (469) | (2) | | (333) | (2) |
| (1) | Includes ($1) million and ($6) million of hedging adjustments on discontinued hedging relationships at September 30, 2019 and December 31, 2018, respectively. |
| (2) | Includes ($378) million and ($213) million of hedging adjustments on discontinued hedging relationships at September 30, 2019 and December 31, 2018, respectively. |
|
| Effect of Derivative Instruments in the Consolidated Statement of Earnings |
| | | | | | | | | | | | | | | | | | | | | | Gains/(Losses) of | | (Dollars in millions) | | Total | | Total Hedge Activity | | For the three months ended September 30: | | 2019 | | 2018 | | 2019 | | 2018 | | Cost of services | | $ | 7,840 | | $ | 7,951 | * | $ | 22 | | $ | 1 | | Cost of sales | | | 1,635 | | | 1,714 | * | | 10 | | | 8 | | Cost of financing | | | 217 | | | 287 | | | (11) | | | (3) | * | SG&A expense | | | 5,024 | | | 4,363 | | | 20 | | | 47 | | Other (income) and expense | | | (31) | | | 275 | | | (561) | | | (63) | | Interest expense | | | 432 | | | 191 | | | (35) | | | (3) | * |
* Reclassified to conform to current period presentation. | | | | | | | | | | | | | | | | | Gain (Loss) Recognized in Earnings | | | Consolidated | | Recognized on | | Attributable to Risk | (Dollars in millions) | | Statement of | | Derivatives | | Being Hedged(2) | For the three months ended September 30: | | Earnings Line Item | | 2019 | | 2018 | | 2019 | | 2018 | Derivative instruments in fair value hedges (1): | | | | | | | | | | | | | | | Interest rate contracts | | Cost of financing | | $ | 3 | | $ | (27) | | $ | 0 | | $ | 33 | | | Interest expense | | | 9 | | | (26) | | | 0 | | | 33 | Derivative instruments not designated as hedging instruments: | | | | | | | | | | | | | | | Foreign exchange contracts | | Other (income) and expense | | | (114) | | | (55) | | | N/A | | | N/A | Equity contracts | | SG&A expense | | | 9 | | | 40 | | | N/A | | | N/A | Total | | | | $ | (94) | | $ | (69) | | $ | 0 | | $ | 66 |
| | | | | | | | | | | | | | | | | | | | | | | | Gain (Loss) Recognized in Earnings and Other Comprehensive Income | | (Dollars in millions) | | | | | | | | Consolidated | | Reclassified | | Amounts Excluded from | | For the three months | | Recognized in OCI | | Statement of | | from AOCI | | Effectiveness Testing(3) | | ended September 30: | | 2019 | | 2018 | | Earnings Line Item | | 2019 | | 2018 | | 2019 | | 2018 | | Derivative instruments in cash flow hedges: | | | | | | | | | | | | | | | | | | | | | | Interest rate contracts | | $ | — | | $ | — | | Cost of financing | | $ | (1) | | $ | — | | $ | — | | $ | — | | | | | | | | | | Interest expense | | | (3) | | | — | | | — | | | — | | Foreign exchange contracts | | | (439) | | | (46) | | Cost of services | | | 22 | | | 1 | | | — | | | — | | | | | | | | | | Cost of sales | | | 10 | | | 8 | | | — | | | — | | | | | | | | | | Cost of financing | | | (20) | | | (18) | * | | — | | | — | | | | | | | | | | SG&A expense | | | 11 | | | 7 | | | — | | | — | | | | | | | | | | Other (income) and expense | | | (447) | | | (8) | | | — | | | — | | | | | | | | | | Interest expense | | | (61) | | | (18) | * | | — | | | — | | Instruments in net investment hedges (4): | | | | | | | | | | | | | | | | | | | | | | Foreign exchange contracts | | | 435 | | | 86 | | Cost of financing | | | — | | | — | | | 7 | | | 9 | * | | | | | | | | | Interest expense | | | — | | | — | | | 20 | | | 9 | * | Total | | $ | (4) | | $ | 40 | | | | $ | (488) | | $ | (28) | | $ | 27 | | $ | 18 | |
* Reclassified to conform to current period presentation. | (1) | The amount includes changes in clean fair values of the derivative instruments in fair value hedging relationships and the periodic accrual for coupon payments required under these derivative contracts. |
| (2) | The amount includes basis adjustments to the carrying value of the hedged item recorded during the period and amortization of basis adjustments recorded on de-designated hedging relationships during the period. |
| (3) | The company’s policy is to recognize all fair value changes in amounts excluded from effectiveness testing in net income each period. |
| (4) | Instruments in net investment hedges include derivative and non-derivative instruments. |
N/A - not applicable | | | | | | | | | | | | | | | | | | | | | | Gains/(Losses) of | | (Dollars in millions) | | Total | | Total Hedge Activity | | For the nine months ended September 30: | | 2019 | | 2018 | | 2019 | | 2018 | | Cost of services | | $ | 24,293 | * | $ | 25,238 | * | $ | 52 | | $ | 29 | | Cost of sales | | | 4,979 | * | | 5,498 | * | | 40 | | | (15) | | Cost of financing | | | 710 | | | 846 | | | (47) | | | 1 | * | SG&A expense | | | 15,171 | | | 14,665 | | | 199 | | | 24 | | Other (income) and expense | | | (850) | | | 968 | | | (358) | | | (449) | | Interest expense | | | 990 | | | 530 | | | (96) | | | 1 | * |
* Reclassified to conform to current period presentation. | | | | | | | | | | | | | | | | | Gain (Loss) Recognized in Earnings | | | Consolidated | | Recognized on | | Attributable to Risk | (Dollars in millions) | | Statement of | | Derivatives | | Being Hedged(2) | For the nine months ended September 30: | | Earnings Line Item | | 2019 | | 2018 | | 2019 | | 2018 | Derivative instruments in fair value hedges (1): | | | | | | | | | | | | | | | Interest rate contracts | | Cost of financing | | $ | 51 | | $ | (138) | | $ | (44) | | $ | 170 | | | Interest expense | | | 105 | | | (128) | | | (89) | | | 157 | Derivative instruments not designated as hedging instruments: | | | | | | | | | | | | | | | Foreign exchange contracts | | Other (income) and expense | | | (27) | | | (148) | | | N/A | | | N/A | Equity contracts | | SG&A expense | | | 153 | | | 38 | | | N/A | | | N/A | Total | | | | $ | 283 | | $ | (377) | | $ | (133) | | $ | 327 |
| | | | | | | | | | | | | | | | | | | | | | | | Gain (Loss) Recognized in Earnings and Other Comprehensive Income | | (Dollars in millions) | | | | | | | | Consolidated | | Reclassified | | Amounts Excluded from | | For the nine months | | Recognized in OCI | | Statement of | | from AOCI | | Effectiveness Testing(3) | | ended September 30: | | 2019 | | 2018 | | Earnings Line Item | | 2019 | | 2018 | | 2019 | | 2018 | | Derivative instruments in cash flow hedges: | | | | | | | | | | | | | | | | | | | | | | Interest rate contracts | | $ | (168) | | $ | — | | Cost of financing | | $ | (2) | | $ | — | | $ | — | | $ | — | | | | | | | | | | Interest expense | | | (5) | | | — | | | — | | | — | | Foreign exchange contracts | | | (630) | | | (134) | | Cost of services | | | 52 | | | 29 | | | — | | | — | | | | | | | | | | Cost of sales | | | 40 | | | (15) | | | — | | | — | | | | | | | | | | Cost of financing | | | (71) | | | (56) | * | | — | | | — | | | | | | | | | | SG&A expense | | | 45 | | | (14) | | | — | | | — | | | | | | | | | | Other (income) and expense | | | (331) | | | (301) | | | — | | | — | | | | | | | | | | Interest expense | | | (146) | | | (52) | * | | — | | | — | | Instruments in net investment hedges (4): | | | | | | | | | | | | | | | | | | | | | | Foreign exchange contracts | | | 306 | | | 509 | | Cost of financing | | | — | | | — | | | 19 | | | 26 | * | | | | | | | | | Interest expense | | | — | | | — | | | 38 | | | 24 | * | Total | | $ | (491) | | $ | 375 | | | | $ | (418) | | $ | (408) | | $ | 57 | | $ | 49 | |
* Reclassified to conform to current period presentation. | (1) | The amount includes changes in clean fair values of the derivative instruments in fair value hedging relationships and the periodic accrual for coupon payments required under these derivative contracts. |
| (2) | The amount includes basis adjustments to the carrying value of the hedged item recorded during the period and amortization of basis adjustments recorded on de-designated hedging relationships during the period. |
| (3) | The company’s policy is to recognize all fair value changes in amounts excluded from effectiveness testing in net income each period. |
| (4) | Instruments in net investment hedges include derivative and non-derivative instruments. |
N/A - not applicable
|